OncoResponse: OncoResponse Scoops Up $14M
SEATTLE, WA, OncoResponse has raised $14 million in new funding from existing investors.
Read full article »
OncoResponse is a Washington-based biotechnology company that researches and develops immunotherapies for the treatment of cancer.
Read more